Corrigendum to “Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study” [Environ. Int. 131 (2019) 104983]

Corrigendum to “Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study” [Environ. Int. 131 (2019) 104983]

Bibliographic Details
Main Authors:	Anne P. Starling, John L. Adgate, Richard F. Hamman, Katerina Kechris, Antonia M. Calafat, Dana Dabelea
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Environment International
Online Access:	http://www.sciencedirect.com/science/article/pii/S0160412023006700

Similar Items

Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study
by: Anne P. Starling, et al.
Published: (2019-10-01)

Prenatal exposure to per- and polyfluoroalkyl substances in association with autism spectrum disorder in the MARBLES study
by: Jiwon Oh, et al.
Published: (2021-02-01)

Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria
by: Andreas-Marius Kaiser, et al.
Published: (2023-07-01)

Prenatal exposure to per- and polyfluoroalkyl substances, fetoplacental hemodynamics, and fetal growth
by: Bethany Knox, et al.
Published: (2024-11-01)

Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach
by: Emma V. Preston, et al.
Published: (2020-06-01)

Prenatal exposure to Per- and polyfluoroalkyl substances and adiposity measures of children at 4 and 6 years: A prospective birth cohort in China
by: Songlin Sun, et al.
Published: (2024-01-01)

Prenatal exposure to per- and polyfluoroalkyl substances and sex-specific associations with offspring adiposity at 10 years of age: Metabolic perturbation plays a role
by: Zheng Wang, et al.
Published: (2024-10-01)

Prospective associations of mid-childhood plasma per- and polyfluoroalkyl substances and pubertal timing
by: Jenny L. Carwile, et al.
Published: (2021-11-01)

Mixture effects of prenatal exposure to per- and polyfluoroalkyl substances and polybrominated diphenyl ethers on maternal and newborn telomere length
by: Stephanie M. Eick, et al.
Published: (2021-06-01)

Prenatal per- and polyfluoroalkyl substances exposure and gut microbiota of infants: A prospective cohort study
by: Honglei Ji, et al.
Published: (2024-01-01)

Prenatal Exposure to Per- and Polyfluoroalkyl Substances, Maternal Thyroid Dysfunction, and Child Autism Spectrum Disorder
by: Hyeong-Moo Shin, et al.
Published: (2022-12-01)

Prenatal exposure to per- and polyfluoroalkyl substances and infant sleep disturbance: A prospective cohort study
by: Yun Huang, et al.
Published: (2023-08-01)

Toxicity of Per- and Polyfluoroalkyl Substances to Nematodes
by: Tingting Ma, et al.
Published: (2023-07-01)

Cord plasma metabolomic signatures of prenatal per- and polyfluoroalkyl substance (PFAS) exposures in the Boston Birth Cohort
by: Zeyu Li, et al.
Published: (2024-12-01)

Association of prenatal exposure to perfluorinated and polyfluoroalkyl substances with childhood neurodevelopment: A systematic review and meta-analysis
by: Dongge Liu, et al.
Published: (2024-02-01)

Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study
by: Qian Chen, et al.
Published: (2018-01-01)

Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years
by: Nan Li, et al.
Published: (2021-02-01)

Elevated per- and polyfluoroalkyl substances (PFASs) in tap water and serum in a community near an abandoned paper mill
by: Rachel A. Bauer, et al.
Published: (2025-07-01)

Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and their influence on inflammatory biomarkers in pregnancy: Findings from the LIFECODES cohort
by: Ram C. Siwakoti, et al.
Published: (2024-12-01)

Exploring the impact of prenatal perfluoroalkyl and polyfluoroalkyl substances exposure on blood pressure in early childhood: A longitudinal analysis
by: Bowen Du, et al.
Published: (2024-04-01)

Prenatal exposure to per-and polyfluoroalkyl substances and child executive function: Evidence from the Shanghai birth cohort study
by: Xuchen Yang, et al.
Published: (2024-01-01)

Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial
by: Pi-I D. Lin, et al.
Published: (2021-03-01)

Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma in the Multiethnic Cohort Study
by: Jongeun Rhee, et al.
Published: (2023-10-01)

Effects of Per- and Polyfluoroalkylated Substances on Female Reproduction
by: María Estefanía González-Alvarez, et al.
Published: (2024-06-01)

Uncovering hydrothermal treatment of per- and polyfluoroalkyl substances
by: Qifeng Fan, et al.
Published: (2023-03-01)

Toxicity of per- and polyfluoroalkyl substances to aquatic vertebrates
by: Tingting Ma, et al.
Published: (2023-01-01)

Advances on immunotoxicities induced by per- and polyfluoroalkylated substances
by: Minyan CHEN, et al.
Published: (2022-02-01)

Per- and Polyfluoroalkyl Substances (PFAS) Mixture during Pregnancy and Postpartum Weight Retention in the New Hampshire Birth Cohort Study (NHBCS)
by: Yuting Wang, et al.
Published: (2023-05-01)

Using non-parametric Bayes shrinkage to assess relationships between multiple environmental and social stressors and neonatal size and body composition in the Healthy Start cohort
by: Sheena E. Martenies, et al.
Published: (2022-11-01)

Mediation effects of DNA methylation and hydroxymethylation on birth outcomes after prenatal per- and polyfluoroalkyl substances (PFAS) exposure in the Michigan mother–infant Pairs cohort
by: Rebekah L. Petroff, et al.
Published: (2023-03-01)

Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort
by: Emma V. Preston, et al.
Published: (2022-07-01)

Electrothermal mineralization of per- and polyfluoroalkyl substances for soil remediation
by: Yi Cheng, et al.
Published: (2024-07-01)

Effects of functional groups of polyfluoroalkyl substances on their removal by nanofiltration
by: Takahiro Fujioka, et al.
Published: (2024-09-01)

Forever Chemicals, Per-and Polyfluoroalkyl Substances (PFAS), in Lubrication
by: Darrius Dias, et al.
Published: (2024-03-01)

A Review: Per- and Polyfluoroalkyl Substances—Biological Degradation
by: Dijana Grgas, et al.
Published: (2023-05-01)

Cardiometabolic health and per and polyfluoroalkyl substances in an Inuit population
by: Amira Aker, et al.
Published: (2023-11-01)

Review of per- and polyfluoroalkyl substances (PFAS) bioaccumulation in earthworms
by: Lawrence P. Burkhard, et al.
Published: (2023-04-01)

Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)
by: Veronika Ehrlich, et al.
Published: (2023-02-01)

Longitudinal trends of per- and polyfluoroalkyl substances in children's serum
by: Jani Koponen, et al.
Published: (2018-12-01)

Associations of per-/polyfluoroalkyl substances with glucocorticoids and progestogens in newborns
by: Hongxiu Liu, et al.
Published: (2020-07-01)